Abstract
Whole genome sequencing (WGS) is increasingly used for clinical and research purposes. Patients and research participants will be required to make decisions about having WGS done and receiving results from it, acknowledging that the context in which they are having it done is constantly changing and evolving, and that therefore all of the future outcomes of the research or clinical procedures cannot be predicted at baseline. In this chapter, we focus primarily on WGS in the context of “healthy” individuals, that is, individuals not selected specifically for having an initial disease or phenotype of interest. Although much of WGS being done today is, for example, to uncover the cause of an undiagnosed disease or to try to help treat a patient diagnosed with cancer, we anticipate that in the coming years WGS will not be restricted to individuals and families affected with rare genetic disorders and diseases, but that rather we are moving toward a future where every individual across society will have their genome sequenced. We discuss how decision-making about WGS may differ from decision-making about past health-related tests, review the limited evidence at present on decision-making about WGS, discuss how the rate of evidence is growing exponentially and so decision-making is a moving target that we can expect to be constantly changing and very dynamic for the foreseeable future, and discuss the challenges and future directions for the field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Altshuler, D., Daly, M. J., et al. (2008). Genetic mapping in human disease. Science, 322(5903), 881–888.
Angrist, M. (2009). Eyes wide open: The personal genome project, citizen science and veracity in informed consent. Personalized Medicine, 6(6), 691–699.
Ashley, E. A., Butte, A. J., et al. (2010). Clinical assessment incorporating a personal genome. Lancet, 375(9725), 1525–1535.
Ball, M. P., Thakuria, J. V., et al. (2012). A public resource facilitating clinical use of genomes. Proceedings of the National Academy of Sciences of the United States of America, 109(30), 11920–11927.
Bandura, D. R., Baranov, V. I., et al. (2009). Mass cytometry: Technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Analytical Chemistry, 81(16), 6813–6822.
Barabasi, A. L., & Oltvai, Z. N. (2004). Network biology: understanding the cell’s functional organization. Nature Reviews Genetics, 5(2), 101–113.
Bernstein, B. E., Birney, E., et al. (2012). An integrated encyclopedia of DNA elements in the human genome. Nature, 489(7414), 57–74.
Biesecker, L. G. (2012). Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: Lessons from the ClinSeq project. Genetics in Medicine, 14(4), 393–398.
Biesecker, L. G., Mullikin, J. C., et al. (2009). The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine. Genome Research, 19(9), 1665–1674.
Bloss, C. S., Ornowski, L., et al. (2010). Consumer perceptions of direct-to-consumer personalized genomic risk assessments. Genetics in Medicine, 12(9), 556–566.
Bloss, C. S., Schork, N. J., et al. (2011). Effect of direct-to-consumer genomewide profiling to assess disease risk. New England Journal of Medicine, 364(6), 524–534.
Brunham, L. R., & Hayden, M. R. (2012). Medicine. Whole-genome sequencing: the new standard of care? Science, 336(6085), 1112–1113.
Cassa, C. A., Savage, S. K., et al. (2012). Disclosing pathogenic genetic variants to research participants: Quantifying an emerging ethical responsibility. Genome Research, 22(3), 421–428.
Chen, R., Mias, G. I., et al. (2012). Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell, 148(6), 1293–1307.
Church, G. M. (2005). The personal genome project. Molecular Systems Biology, 1(2005), 0030.
Codori, A. M., Hanson, R., et al. (1994). Self-selection in predictive testing for Huntington’s disease. American Journal of Medical Genetics, 54(3), 167–173.
International Human Genome Sequencing Consortium. (2004). Finishing the euchromatic sequence of the human genome. Nature, 431(2011), 931–945.
National Research Council (2011). Toward precision medicine: Building a knowledge network for biomedical research and a new taxonomy of disease. Washington DC: National Academy of Sciences.
Creighton, S., Almqvist, E. W., et al. (2003). Predictive, pre-natal and diagnostic genetic testing for Huntington’s disease: The experience in Canada from 1987 to 2000. Clinical Genetics, 63(6), 462–475.
Dewey, F. E., Chen, R., et al. (2011). Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genetics, 7(9), e1002280.
Dohany, L., Gustafson, S., et al. (2012). Psychological distress with direct-to-consumer genetic testing: A case report of an unexpected BRCA positive test result. Journal of Genetic Counseling, 21(3), 399–401.
Drmanac, R., Sparks, A. B., et al. (2010). Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science, 327(5961), 78–81.
Eid, J., Fehr, A., et al. (2009). Real-time DNA sequencing from single polymerase molecules. Science, 323(5910), 133–138.
Elwyn, G., O’Connor, A., et al. (2006). Developing a quality criteria framework for patient decision aids: Online international delphi consensus process. BMJ, 333(7565), 417.
Emilsson, V., Thorleifsson, G., et al. (2008). Genetics of gene expression and its effect on disease. Nature, 452(7186), 423–428.
Fabsitz, R. R., McGuire, A., et al. (2010). Ethical and practical guidelines for reporting genetic research results to study participants: Updated guidelines from a national heart, lung, and blood institute working group. Circulation: Cardiovascular Genetics, 3(6), 574–580.
Facio, F. M., Brooks, S., et al. (2011). Motivators for participation in a whole-genome sequencing study: Implications for translational genomics research. European Journal of Human Genetics, 19(12), 1213–1217.
Facio, F. M., Eidem, H., et al. (2012). Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study. European Journal of Human Genetics, 21(3), 261–265.
Feldman-Stewart, D., Brennenstuhl, S., et al. (2006). An explicit values clarification task: Development and validation. Patient Education and Counseling, 63(3), 350–356.
Gollust, S. E., Gordon, E. S., et al. (2012). Motivations and perceptions of early adopters of personalized genomics: Perspectives from research participants. Public Health Genomics, 15(1), 22–30.
Green, E. D., & Guyer, M. S. (2011). Charting a course for genomic medicine from base pairs to bedside. Nature, 470(7333), 204–213.
Green, M. J., Peterson, S. K., et al. (2004). Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: A randomized controlled trial. JAMA, 292(4), 442–452.
Halder, I., Shriver, M., et al. (2008). A panel of ancestry informative markers for estimating individual biogeographical ancestry and admixture from four continents: Utility and applications. Human Mutation, 29(5), 648–658.
Han, J. D., Bertin, N., et al. (2004). Evidence for dynamically organized modularity in the yeast protein–protein interaction network. Nature, 430(6995), 88–93.
Hatemi, P. K., & McDermott, R. (2012). The genetics of politics: Discovery, challenges, and progress. Trends in Genetics, 28(10), 525–533.
Hensley Alford, S., McBride, C. M., et al. (2011). Participation in genetic testing research varies by social group. Public Health Genomics, 14(2), 85–93.
Jibaja-Weiss, M. L., Volk, R. J., et al. (2006). Preliminary testing of a just-in-time, user-defined values clarification exercise to aid lower literate women in making informed breast cancer treatment decisions. Health Expectations, 9(3), 218–231.
Jibaja-Weiss, M. L., & Volk, R. J. (2007). Utilizing computerized entertainment education in the development of decision aids for lower literate and naive computer users. Journal of Health Communication, 12(7), 681–697.
Jibaja-Weiss, M. L., Volk, R. J., et al. (2011). Entertainment education for breast cancer surgery decisions: a randomized trial among patients with low health literacy. Patient Education and Counseling, 84(1), 41–48.
Kaphingst, K., Facio, F., et al. (2012). Effects of informed consent for individual genome sequencing on relevant knowledge. Clinical Genetics, 82(5), 408–415.
Koenig, L. B., McGue, M., et al. (2005). Genetic and environmental influences on religiousness: Findings for retrospective and current religiousness ratings. Journal of Personality, 73(2), 471–488.
Kravets, D. (2010). Privacy in peril: Lawyers, nations clamor for Google Wi-Fi data. Wired Magazine.
Lander, E. S., Linton, L. M., et al. (2001). Initial sequencing and analysis of the human genome. Nature, 409(6822), 860–921.
Lerman, C., Croyle, R. T., et al. (2002). Genetic testing: Psychological aspects and implications. Journal of Consulting and Clinical Psychology, 70(3), 784–797.
Lerman, C., Narod, S., et al. (1996). BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA, 275(24), 1885–1892.
Levy, S., Sutton, G., et al. (2007). The diploid genome sequence of an individual human. PLoS Biology, 5(10), e254.
Lin, Z., Altman, R. B., et al. (2006). Confidentiality in genome research. Science, 313(5786), 441–442.
Lunshof, J. E., Bobe, J., et al. (2010). Personal genomes in progress: from the human genome project to the personal genome project. Dialogues in Clinical Neuroscience, 12(1), 47–60.
Lunshof, J. E., Chadwick, R., et al. (2008). From genetic privacy to open consent. Nature Reviews Genetics, 9(5), 406–411.
Luscombe, N. M., Babu, M. M., et al. (2004). Genomic analysis of regulatory network dynamics reveals large topological changes. Nature, 431(7006), 308–312.
McBride, C. M., Alford, S. H., et al. (2009). Characteristics of users of online personalized genomic risk assessments: Implications for physician-patient interactions. Genetics in Medicine, 11(8), 582–587.
McGuire, A. L., & Gibbs, R. A. (2006). Genetics. No longer de-identified. Science, 312(5772), 370–371.
O’Connor, A. M., Bennett, C. L., et al. (2009). Decision aids for people facing health treatment or screening decisions. The Cochrane Database of Systamatic Reviews, 3, CD001431.
Pinto, S., Roseberry, A. G., et al. (2004). Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science, 304(5667), 110–115.
Reid, R. J., McBride, C. M,. et al. (2012). Association between health-service use and multiplex genetic testing. Genetics in Medicine, 14(10), 852–859.
Roberts, J. S., Barber, M., et al. (2004). Who seeks genetic susceptibility testing for Alzheimer’s disease? Findings from a multisite, randomized clinical trial. Genetics in Medicine, 6(4), 197–203.
Roberts, J. S., LaRusse, S. A., et al. (2003). Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease. Alzheimer Disease and Associated Disorders, 17(2), 86–93.
Sanderson, S. C., Suckiel, S. A., Zweig, M., Bottinger, E. P., Jabs, E. W., Richardson, L. D. (2016). Development and preliminary evaluation of an online educational video about whole-genome sequencing for research participants, patients, and the general public. Genetics in Medicine, 18(5), 501–512.
Sanderson, S. C., Linderman, M. D., Suckiel, S. A., Diaz, G. A., Zinberg, R. E., Ferryman, K., Wasserstein, M., Kasarskis, A., Schadt, E. E. (2016). Motivations, concerns and preferences of personal genome sequencing research participants: Baseline findings from the HealthSeq project. European Journal of Human Genetics, 24(1),14–20.
Schadt, E. E. (2012). The changing privacy landscape in the era of big data. Molecular Systems Biology, 8, 612.
Schadt, E. E., Turner, S., et al. (2010). A window into third-generation sequencing. Human Molecular Genetics, 19(R2), R227–R240.
Schadt, E. E., Woo, S., et al. (2012). Bayesian method to predict individual SNP genotypes from gene expression data. Nature Genetics, 44(5), 603–608.
Sheehan, J., & Sherman, K. A. (2012). Computerised decision aids: A systematic review of their effectiveness in facilitating high-quality decision-making in various health-related contexts. Patient Education and Counseling, 88(1), 69–86.
Speicher, M. R., Geigl, J. B., et al. (2010). Effect of genome-wide association studies, direct-to-consumer genetic testing, and high-speed sequencing technologies on predictive genetic counselling for cancer risk. Lancet Oncology, 11(9), 890–898.
Tabor, H. K., Stock, J., et al. (2012). Informed consent for whole genome sequencing: A qualitative analysis of participant expectations and perceptions of risks, benefits, and harms. American Journal of Medical Genetics Part A, 158A(6), 1310–1319.
van der Steenstraten, I. M., Tibben, A., et al. (1994). Predictive testing for Huntington disease: Nonparticipants compared with participants in the Dutch program. American Journal of Human Genetics, 55(4), 618–625.
Venter, J. C., Adams, M. D., et al. (2001). The sequence of the human genome. Science, 291(5507), 1304–1351.
Volk, R. J., Jibaja-Weiss, M. L., et al. (2008). Entertainment education for prostate cancer screening: A randomized trial among primary care patients with low health literacy. Patient Education and Counseling, 73(3), 482–489.
Walker, A. P. (2009). The practice of genetic counseling. In W. S. Uhlmann, J. B. Yashar (Eds.),. A Guide to genetic counseling (pp. 1–35). Hoboken, New Jersey: Wiley.
Wheeler, D. A., Srinivasan, M., et al. (2008). The complete genome of an individual by massively parallel DNA sequencing. Nature, 452(7189), 872–876.
Zerhouni, E. (2003). Medicine. The NIH roadmap. Science, 302(5642), 63–72.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sanderson, S.C., Schadt, E.E. (2016). Decision-Making in the Age of Whole Genome Sequencing. In: Diefenbach, M., Miller-Halegoua, S., Bowen, D. (eds) Handbook of Health Decision Science. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3486-7_25
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3486-7_25
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-3484-3
Online ISBN: 978-1-4939-3486-7
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)